- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for BioLine RX Ltd (BLRX)
| Open: | 2.5400 | Day's Range: | 2.4200 - 2.5400 | Volume: | 12,100 | Bid: | 2.4700 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 2.5400 | 52wk Range: | 2.3800 - 6.8700 | 1-Yr Rtn: | - | Ask: | 2.5100 |
Key Statistics for BLRX
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (-) | - |
| Earnings Per Share () (ttm) | - |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 44.19 |
| Shares Outstanding (M) | 17.61 |
| Enterprise Value (M ILS) (ttm) | - |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 08/28/2012 |
More BLRX Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for BLRX
- Operating
- Investing
- Financing (M/ILS)
Company Profile & Key Executives for BLRX
BioLineRx Ltd. is a biopharmaceutical development company. The Company develops clinical-stage therapeutic pharmaceutical drugs.
| Aharon SchwartzChairman | Kinneret Livnat SavitskyChief Executive Officer |
| Philip SerlinCFO/COO | Nir GamlielVP:Business Development |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page